Display options
Share it on

JCI Insight. 2021 Jul 22;6(14). doi: 10.1172/jci.insight.137708.

mTORC1 is a mechanosensor that regulates surfactant function and lung compliance during ventilator-induced lung injury.

JCI insight

Hyunwook Lee, Qinqin Fei, Adam Streicher, Wenjuan Zhang, Colleen Isabelle, Pragi Patel, Hilaire C Lam, Antonio Arciniegas-Rubio, Miguel Pinilla-Vera, Diana P Amador-Munoz, Diana Barragan-Bradford, Angelica Higuera-Moreno, Rachel K Putman, Lynette M Sholl, Elizabeth P Henske, Christopher M Bobba, Natalia Higuita-Castro, Emily M Shalosky, R Duncan Hite, John W Christman, Samir N Ghadiali, Rebecca M Baron, Joshua A Englert

Affiliations

  1. Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, and.
  2. The Dorothy M. Davis Heart and Lung Research Institute, The Ohio State Wexner Medical Center, Columbus, Ohio, USA.
  3. Division of Pulmonary and Critical Care Medicine, Department of Medicine, and.
  4. Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  5. Department of Biomedical Engineering, The Ohio State University, Columbus, Ohio, USA.
  6. Division of Pulmonary, Critical Care, and Sleep Medicine, The University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

PMID: 34138757 PMCID: PMC8410036 DOI: 10.1172/jci.insight.137708

Abstract

The acute respiratory distress syndrome (ARDS) is a highly lethal condition that impairs lung function and causes respiratory failure. Mechanical ventilation (MV) maintains gas exchange in patients with ARDS but exposes lung cells to physical forces that exacerbate injury. Our data demonstrate that mTOR complex 1 (mTORC1) is a mechanosensor in lung epithelial cells and that activation of this pathway during MV impairs lung function. We found that mTORC1 is activated in lung epithelial cells following volutrauma and atelectrauma in mice and humanized in vitro models of the lung microenvironment. mTORC1 is also activated in lung tissue of mechanically ventilated patients with ARDS. Deletion of Tsc2, a negative regulator of mTORC1, in epithelial cells impairs lung compliance during MV. Conversely, treatment with rapamycin at the time MV is initiated improves lung compliance without altering lung inflammation or barrier permeability. mTORC1 inhibition mitigates physiologic lung injury by preventing surfactant dysfunction during MV. Our data demonstrate that, in contrast to canonical mTORC1 activation under favorable growth conditions, activation of mTORC1 during MV exacerbates lung injury and inhibition of this pathway may be a novel therapeutic target to mitigate ventilator-induced lung injury during ARDS.

Keywords: Pulmonary surfactants; Pulmonology; Signal transduction

References

  1. J Appl Physiol (1985). 2014 Dec 1;117(11):1231-42 - PubMed
  2. Mol Cell Biol. 2011 Mar;31(5):1054-65 - PubMed
  3. BMC Pulm Med. 2014 Oct 31;14:168 - PubMed
  4. J Vis Exp. 2011 Feb 21;(48): - PubMed
  5. N Engl J Med. 2013 Nov 28;369(22):2126-36 - PubMed
  6. Am J Respir Cell Mol Biol. 2013 Jul;49(1):156-64 - PubMed
  7. J Appl Physiol (1985). 2004 Aug;97(2):704-15 - PubMed
  8. PLoS One. 2012;7(10):e47258 - PubMed
  9. Biochem J. 2004 Jun 15;380(Pt 3):795-804 - PubMed
  10. Biochim Biophys Acta. 2013 Mar;1831(3):612-25 - PubMed
  11. Am J Physiol Lung Cell Mol Physiol. 2014 Jun 15;306(12):L1117-28 - PubMed
  12. N Engl J Med. 2000 May 4;342(18):1301-8 - PubMed
  13. Can J Biochem Physiol. 1959 Aug;37(8):911-7 - PubMed
  14. Am J Respir Cell Mol Biol. 2011 May;44(5):725-38 - PubMed
  15. J Appl Physiol (1985). 2005 Aug;99(2):624-33 - PubMed
  16. Science. 1992 Aug 14;257(5072):973-7 - PubMed
  17. Ann Biomed Eng. 2016 Dec;44(12):3632-3644 - PubMed
  18. Antioxid Redox Signal. 2006 Sep-Oct;8(9-10):1775-89 - PubMed
  19. J Biol Chem. 2005 Nov 25;280(47):39505-9 - PubMed
  20. Intensive Care Med. 2015 Feb;41(2):222-30 - PubMed
  21. Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):357-62 - PubMed
  22. Mol Cell. 2010 Oct 22;40(2):310-22 - PubMed
  23. Microvasc Res. 2009 Jan;77(1):46-52 - PubMed
  24. Cell Signal. 2010 Oct;22(10):1469-76 - PubMed
  25. Sci Rep. 2017 Sep 14;7(1):11623 - PubMed
  26. Nat Med. 2010 Jul;16(7):767-73 - PubMed
  27. Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4741-6 - PubMed
  28. Am J Physiol Renal Physiol. 2017 Apr 1;312(4):F654-F660 - PubMed
  29. Hypertension. 2009 Dec;54(6):1321-7 - PubMed
  30. N Engl J Med. 2017 Nov 9;377(19):1904-1905 - PubMed
  31. N Engl J Med. 2011 Apr 28;364(17):1595-606 - PubMed
  32. Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):857-866 - PubMed
  33. Cancer Res. 2017 Jun 15;77(12):3255-3267 - PubMed
  34. FASEB J. 2020 Sep;34(9):12785-12804 - PubMed
  35. J Clin Invest. 1982 Sep;70(3):673-83 - PubMed
  36. J Biol Chem. 1999 Nov 12;274(46):32596-602 - PubMed
  37. Am J Physiol Lung Cell Mol Physiol. 2003 Oct;285(4):L785-97 - PubMed
  38. Autophagy. 2016 Dec;12(12):2286-2299 - PubMed
  39. Am J Physiol Lung Cell Mol Physiol. 2005 Sep;289(3):L489-96 - PubMed
  40. Am J Respir Cell Mol Biol. 1998 Apr;18(4):562-9 - PubMed
  41. BMC Bioinformatics. 2006 Mar 09;7:123 - PubMed
  42. Sci Rep. 2016 Feb 18;6:20156 - PubMed
  43. Am J Respir Crit Care Med. 2018 May 15;197(10):1328-1339 - PubMed
  44. Am J Respir Crit Care Med. 2012 Apr 1;185(7):702-8 - PubMed
  45. N Engl J Med. 2006 Apr 27;354(17):1775-86 - PubMed
  46. Am J Respir Cell Mol Biol. 2009 Aug;41(2):237-45 - PubMed
  47. Science. 2008 Jun 13;320(5882):1496-501 - PubMed
  48. J Orthop Res. 2009 Sep;27(9):1157-61 - PubMed
  49. Crit Care Med. 2000 Jul;28(7):2545-51 - PubMed
  50. Genesis. 2007 Sep;45(9):593-605 - PubMed
  51. Cell Mol Bioeng. 2010 Dec 1;3(4):415-427 - PubMed
  52. Nat Cell Biol. 2001 Nov;3(11):1014-9 - PubMed
  53. Am J Respir Cell Mol Biol. 2016 Nov;55(5):722-735 - PubMed
  54. Am Rev Respir Dis. 1987 Aug;136(2):426-44 - PubMed
  55. J Immunol. 2015 Oct 15;195(8):3901-11 - PubMed
  56. FASEB J. 2014 Oct;28(10):4470-81 - PubMed
  57. J Clin Invest. 2018 Jan 2;128(1):74-84 - PubMed
  58. Oncogene. 2006 Mar 30;25(14):2105-12 - PubMed
  59. N Engl J Med. 2005 Oct 20;353(16):1685-93 - PubMed
  60. Nature. 2014 Sep 18;513(7518):440-3 - PubMed
  61. Am J Respir Crit Care Med. 2007 Oct 15;176(8):786-94 - PubMed
  62. JCI Insight. 2019 Jan 24;4(2): - PubMed
  63. JAMA. 2012 Jun 20;307(23):2526-33 - PubMed
  64. Respir Res. 2001;2(6):353-64 - PubMed
  65. Eur Respir J. 1998 Mar;11(3):745-57 - PubMed
  66. Adv Colloid Interface Sci. 2016 Dec;238:62-87 - PubMed
  67. Purinergic Signal. 2017 Sep;13(3):363-386 - PubMed
  68. Cell. 2017 Apr 6;169(2):361-371 - PubMed
  69. Respir Res. 2003;4:4 - PubMed
  70. ACS Nano. 2015 May 26;9(5):5413-21 - PubMed
  71. JCI Insight. 2018 Feb 8;3(3): - PubMed
  72. Am J Respir Cell Mol Biol. 2001 Jul;25(1):35-44 - PubMed
  73. PLoS One. 2010 Dec 21;5(12):e14399 - PubMed
  74. FASEB J. 2012 Aug;26(8):3351-64 - PubMed
  75. Am J Physiol. 1999 Jul;277(1):L167-73 - PubMed
  76. Am J Med Sci. 2012 Jun;343(6):446-51 - PubMed
  77. BMJ. 2021 Mar 10;372:n436 - PubMed
  78. Am J Respir Cell Mol Biol. 2003 Mar;28(3):305-15 - PubMed
  79. Semin Cell Dev Biol. 2014 Dec;36:68-78 - PubMed
  80. Am J Respir Cell Mol Biol. 2015 Jul;53(1):33-41 - PubMed
  81. Genesis. 2007 Feb;45(2):101-6 - PubMed
  82. Semin Respir Crit Care Med. 2006 Aug;27(4):377-88 - PubMed
  83. J Biol Chem. 2011 Sep 16;286(37):32651-60 - PubMed
  84. Intensive Care Med. 2006 Jan;32(1):24-33 - PubMed
  85. Am J Physiol Lung Cell Mol Physiol. 2005 Nov;289(5):L834-41 - PubMed
  86. Science. 2013 Jul 26;341(6144):1236566 - PubMed

Publication Types

Grant support